In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on Strata Skin Sciences (SSKN), with a price target of $6.00. The company’s shares closed last Monday at $1.04, close to its 52-week low of $0.98.
According to TipRanks.com, Kalia is a 4-star analyst with an average return of 1.2% and a 50.4% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Edwards Lifesciences.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Strata Skin Sciences with a $6.00 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $3.27 and a one-year low of $0.98. Currently, Strata Skin Sciences has an average volume of 52.24K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
STRATA Skin Sciences, Inc. is a medical technology company. The firm engages in the design, development, and commercializing of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
